| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 23 |
| 1 | DEXAMETHASONE 1.5 MG | 23 |
| 2 | CARBOPLATIN | 16 |
| 3 | RIVAROXABAN | 16 |
| 4 | UPADACITINIB | 16 |
| 5 | PEMETREXED DISODIUM | 14 |
| 6 | CYCLOPHOSPHAMIDE | 13 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 13 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 13 |
| 9 | PREDNISONE | 13 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | L-PHENYLALANINE | 1 | 0.0127 |
| 1 | AMLODIPINE BESYLATE AND ATORVASTATIN CALCIUM | 1 | 0.0115 |
| 2 | BEVACIZUMAB-ADCD | 1 | 0.0049 |
| 3 | PROCAINAMIDE HYDROCHLORIDE | 1 | 0.0040 |
| 4 | NAXITAMAB | 1 | 0.0040 |
| 5 | ERAVACYCLINE | 1 | 0.0034 |
| 6 | TOVORAFENIB | 1 | 0.0031 |
| 7 | MEXILETINE HYDROCHLORIDE | 1 | 0.0024 |
| 8 | BARICITINIB | 6 | 0.0020 |
| 9 | MOMETASONE FUROATE MONOHYDRATE | 1 | 0.0020 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 41 |
| 1 | Platinum-based Drug [EPC] | 29 |
| 2 | Janus Kinase Inhibitor [EPC] | 24 |
| 3 | Factor Xa Inhibitor [EPC] | 20 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 19 |
| 5 | Proton Pump Inhibitor [EPC] | 17 |
| 6 | Alkylating Drug [EPC] | 16 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 14 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 13 |
| 9 | Interleukin-6 Receptor Antagonist [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Glycolipid Disialoganglioside-directed Antibody [EPC] | 1 | 0.0009 |
| 1 | Hypoxia-inducible Factor Prolyl Hydroxylase Inhibitor [EPC] | 2 | 0.0009 |
| 2 | Interferon alfa-2b [EPC] | 1 | 0.0005 |
| 3 | Erythroid Maturation Agent [EPC] | 1 | 0.0004 |
| 4 | Interleukin-1 Receptor Antagonist [EPC] | 5 | 0.0003 |
| 5 | Anti-coagulant [EPC] | 1 | 0.0003 |
| 6 | Amyloid Beta-directed Antibody [EPC] | 1 | 0.0003 |
| 7 | Tetracycline-class Antibacterial [EPC] | 2 | 0.0003 |
| 8 | Antiseptic [EPC] | 1 | 0.0002 |
| 9 | Chloride Channel Activator [EPC] | 2 | 0.0002 |